UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study

Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1388-1392

2014

Volltextzugriff (PDF)

Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography

Annals of the rheumatic diseases, 2012-07, Vol.71 (7), p.1170-1176

2012

Volltextzugriff (PDF)

Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis

Medicine (Baltimore), 2016-02, Vol.95 (8), p.e2368-e2368

2016

Volltextzugriff (PDF)

Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients

Medicine (Baltimore), 2014-07, Vol.93 (5), p.194-201

2014

Volltextzugriff (PDF)

Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids

Annals of the rheumatic diseases, 2022-09, Vol.81 (9), p.1290-1300

2022

Volltextzugriff (PDF)

Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis

Annals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1624-1634

2017

Volltextzugriff (PDF)

Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)

Annals of the rheumatic diseases, 2014-10, Vol.73 (10), p.1826-1832

2014

Volltextzugriff (PDF)

Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study

Medicine (Baltimore), 2015-02, Vol.94 (5), p.e486-e486

2015

Volltextzugriff (PDF)

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis

Annals of the rheumatic diseases, 2013-09, Vol.72 (9), p.1481-1487

2013

Volltextzugriff (PDF)

Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis

Journal of internal medicine, 2024-05, Vol.295 (5), p.651-667

2024

Volltextzugriff (PDF)

Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center

Autoimmunity reviews, 2016-01, Vol.15 (1), p.9-15

2016

Volltextzugriff (PDF)

Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis

Annals of the rheumatic diseases, 2014-03, Vol.73 (3), p.616-623

2014

Volltextzugriff (PDF)

Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis

Frontiers in immunology, 2023-02, Vol.14, p.1137794

2023

Volltextzugriff (PDF)

Biological treatments in giant cell arteritis & Takayasu arteritis

European journal of internal medicine, 2018-04, Vol.50, p.12-19

2018

Volltextzugriff (PDF)

Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways

Frontiers in immunology, 2018-04, Vol.9, p.809-809

2018

Volltextzugriff (PDF)

Polymyalgia rheumatica

The Lancet (British edition), 2023-10, Vol.402 (10411), p.1459-1472

2023

Volltextzugriff (PDF)

Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis

Arthritis care & research (2010), 2010-06, Vol.62 (6), p.835-841

2010

Volltextzugriff (PDF)

The Expanding Role of Imaging in Systemic Vasculitis

Rheumatic diseases clinics of North America, 2016-11, Vol.42 (4), p.733-751

2016

Volltextzugriff (PDF)

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis

Annals of the rheumatic diseases, 2022-04, Vol.81 (4), p.524-536

2022

Volltextzugriff (PDF)

Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis

Seminars in arthritis and rheumatism, 2014-06, Vol.43 (6), p.772-777

2014

Volltextzugriff (PDF)

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

Annals of the rheumatic diseases, 2012-04, Vol.71 (4), p.484-492

2012

Volltextzugriff (PDF)

Evaluation of Aortic Inflammation Using Computed Tomographic Angiography: Vasculitis, Atherosclerosis, or Both

Journal of the American Geriatrics Society (JAGS), 2015-02, Vol.63 (2), p.415-416

2015

Volltextzugriff (PDF)

Advances in the Diagnosis of Large Vessel Vasculitis

Rheumatic diseases clinics of North America, 2015-02, Vol.41 (1), p.125-140

2015

Volltextzugriff (PDF)

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (6), p.1177-1186

2016

Volltextzugriff (PDF)

Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies

Rheumatology (Oxford, England), 2020-05, Vol.59 (Supplement_3), p.iii17-iii27

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case–control study

Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography

Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis

Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients

Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids

Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis

Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation)

Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis

Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis

Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center

Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis

Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis

Biological treatments in giant cell arteritis & Takayasu arteritis

Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways

Polymyalgia rheumatica

Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis

The Expanding Role of Imaging in Systemic Vasculitis

Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis

Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

Evaluation of Aortic Inflammation Using Computed Tomographic Angiography: Vasculitis, Atherosclerosis, or Both

Advances in the Diagnosis of Large Vessel Vasculitis

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies

Suchergebnisse filtern